P329: HIGH IMMUNOPROTEASOME ACTIVITY AS NOVEL INDICATOR FOR SENSITIVITY TO BORTEZOMIB-CONTAINING CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS FROM CHILDREN’S ONCOLOGY GROUP TRIAL AALL1231

Bibliographic Details
Title: P329: HIGH IMMUNOPROTEASOME ACTIVITY AS NOVEL INDICATOR FOR SENSITIVITY TO BORTEZOMIB-CONTAINING CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS FROM CHILDREN’S ONCOLOGY GROUP TRIAL AALL1231
Authors: Margot Roeten, Suzanne van Dijk, Johan van Meerloo, Zinia Kwidama, Gaya Jenkins, David Teachey, Meenakshi Devidas, Mignon Loh, Gertjan Kaspers, Sonja Zweegman, Gerrit Jansen, Terzah Horton, Jacqueline Cloos
Source: HemaSphere, Vol 7, p e81299a0 (2023)
Publisher Information: Wiley, 2023.
Publication Year: 2023
Collection: LCC:Diseases of the blood and blood-forming organs
Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2572-9241
Relation: http://journals.lww.com/10.1097/01.HS9.0000968228.81299.a0; https://doaj.org/toc/2572-9241
DOI: 10.1097/01.HS9.0000968228.81299.a0
Access URL: https://doaj.org/article/40d3b42d44514f25bb8ba0bffe07ecbd
Accession Number: edsdoj.40d3b42d44514f25bb8ba0bffe07ecbd
Database: Directory of Open Access Journals
More Details
ISSN:25729241
DOI:10.1097/01.HS9.0000968228.81299.a0
Published in:HemaSphere
Language:English